Maren Haase
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maren Haase has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Armin Baiker
Bavarian Health and Food Safety Authority, 85764 Oberschleissheim, Germany
4 shared publications - Anna Dinkelmeier
Bavarian Health and Food Safety Authority, Oberschleißheim, Germany ;
3 shared publications - Melanie Pavlovic
Bavarian Health and Food Safety Authority (LGL), 85764 Oberschleissheim, Germany
3 shared publications - Thorsten Stellberger
Bavarian Health and Food Safety Authority, Oberschleissheim, Bavaria, Germany
3 shared publications - Ulrich Busch
Bavarian Health and Food Safety Authority (LGL), Veterinärstr. 2, 85764 Oberschleißheim, Germany
3 shared publications Jessica Hellinckx
Bavarian Health and Food Safety Authority (LGL), Veterinaerstr. 2, 85764, Oberschleissheim, Germany
2 shared publications
Latest Publications
- Open Access
- 16 September 2021
- Published by MDPI AG in Microorganisms
- Vol. 9 (9) , 1967
In Vitro Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617.2 (Delta)
Rapid antigen tests (RATs) are an integral part of SARS-CoV-2 containment strategies. As emerging variants of concern (VOCs) displace the initially circulating strains, it is crucial that RATs do not fail to detect these new variants. In this study, four RATs for nasal swab testing were investigated using cultured strains of B.1.1 (non-VOC), B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617.2 (Delta). Based on dilution series in cell culture medium and pooled saliva, the limit of detection of these RATs was determined in a laboratory setting. Further investigations on cross-reactivity were conducted using recombinant N-protein from seasonal human coronaviruses (hCoVs). RATs evaluated showed an overall comparable performance with cultured strains of the non-VOC B.1.1 and the VOCs Alpha, Beta, Gamma, and Delta. No cross-reactivity was detected with recombinant N-protein of the hCoV strains HKU1, OC43, NL63, and 229E. A continuous evaluation of SARS-CoV-2 RAT performance is required, especially with regard to evolving mutations. Moreover, cross-reactivity and interference with pathogens and other substances on the test performance of RATs should be consistently investigated to ensure suitability in the context of SARS-CoV-2 containment.
- 16 September 2021
- Published by MDPI AG in Microorganisms
- Vol. 9 (9) , 1967
Open AccessIn Vitro Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617.2 (Delta)
Rapid antigen tests (RATs) are an integral part of SARS-CoV-2 containment strategies. As emerging variants of concern (VOCs) displace the initially circulating strains, it is crucial that RATs do not fail to detect these new variants. In this study, four RATs for nasal swab testing were investigated using cultured strains of B.1.1 (non-VOC), B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617.2 (Delta). Based on dilution series in cell culture medium and pooled saliva, the limit of detection of these RATs was determined in a laboratory setting. Further investigations on cross-reactivity were conducted using recombinant N-protein from seasonal human coronaviruses (hCoVs). RATs evaluated showed an overall comparable performance with cultured strains of the non-VOC B.1.1 and the VOCs Alpha, Beta, Gamma, and Delta. No cross-reactivity was detected with recombinant N-protein of the hCoV strains HKU1, OC43, NL63, and 229E. A continuous evaluation of SARS-CoV-2 RAT performance is required, especially with regard to evolving mutations. Moreover, cross-reactivity and interference with pathogens and other substances on the test performance of RATs should be consistently investigated to ensure suitability in the context of SARS-CoV-2 containment.
- 27 July 2017
- Published by SAGE Publications in Human Gene Therapy Methods
(RT)-qPCR for detection of and differentiation between RNA and DNA of HIV-1-based lentiviral vectors
The purpose of the described method is the detection of and differentiation between RNA and DNA of HIV-derived lentiviral vectors (LV) in cell culture supernatants and swab samples. For the analytical surveillance of genetic engineering operations methods for the detection of the HIV-1 based LV generations are required. Furthermore, for research issues, it is important to prove the absence of LV particles for downgrading experimental settings in terms of the biosafety level. Here a qPCR method targeting the LTR U5 subunit and the start sequence of the packaging signal ψ is described. Numerous controls are included in order to monitor the technical procedure.
- 27 July 2017
- Published by SAGE Publications in Human Gene Therapy Methods
(RT)-qPCR for detection of and differentiation between RNA and DNA of HIV-1-based lentiviral vectors
The purpose of the described method is the detection of and differentiation between RNA and DNA of HIV-derived lentiviral vectors (LV) in cell culture supernatants and swab samples. For the analytical surveillance of genetic engineering operations methods for the detection of the HIV-1 based LV generations are required. Furthermore, for research issues, it is important to prove the absence of LV particles for downgrading experimental settings in terms of the biosafety level. Here a qPCR method targeting the LTR U5 subunit and the start sequence of the packaging signal ψ is described. Numerous controls are included in order to monitor the technical procedure.
- 19 July 2017
- Published by Springer Nature in Virus Genes
- Vol. 53 (5) , 749-757
Strategies and methods for the detection and identification of viral vectors
The production and application of viral vectors are frequently performed genetic engineering operations. HIV-1-based lentiviral vectors, AAV2-based, and adenoviral vectors are amongst the most abundant viral vectors utilized for gene delivery. They are generally classified into risk group 1 or 2 (according to EU directive 2000/54/EC on the protection of workers from risks related to exposure to biological agents at work).
- 19 July 2017
- Published by Springer Nature in Virus Genes
- Vol. 53 (5) , 749-757
Strategies and methods for the detection and identification of viral vectors
The production and application of viral vectors are frequently performed genetic engineering operations. HIV-1-based lentiviral vectors, AAV2-based, and adenoviral vectors are amongst the most abundant viral vectors utilized for gene delivery. They are generally classified into risk group 1 or 2 (according to EU directive 2000/54/EC on the protection of workers from risks related to exposure to biological agents at work).
- 11 January 2017
- Published by Springer Nature in Journal of Consumer Protection and Food Safety
- Vol. 12 (S1) , 67-74
Strategien zum Nachweis und der Identifizierung viraler Vektoren
- 11 January 2017
- Published by Springer Nature in Journal of Consumer Protection and Food Safety
- Vol. 12 (S1) , 67-74
Strategien zum Nachweis und der Identifizierung viraler Vektoren